Bailey Eric, Frishman William H
From the Department of Medicine, New York University Grossman School of Medicine, New York, NY.
Departments of Medicine and Cardiology, New York Medical College/Westchester Medical Center, Valhalla, NY.
Cardiol Rev. 2023;31(3):173-175. doi: 10.1097/CRD.0000000000000458. Epub 2022 May 16.
The coronavirus disease 2019 (COVID-19) pandemic has taken a massive toll on healthcare systems internationally. Severe illness has been seen in a range of patient populations, but those living with cardiovascular disease have suffered to a greater extent, likely because of their comorbidities. In patients with diabetes, hypertension, heart failure, and other chronic illnesses, COVID-19 has manifested severe illnesses such as coagulopathies, myocarditis, and arrhythmias, complicating the disease course for those already suffering from underlying illness. There have been numerous studies done exploring the cardiovascular complications of COVID-19. Some of the more concerning findings have revealed a correlation between severe illness and the increasing likelihood for developing cardiovascular manifestations. However, what is more concerning were the studies revealing the presence of myocarditis and other cardiac sequelae in previously healthy patients with mild or asymptomatic COVID-19. The goal of this article is to review the literature to compile information available about whether there is a significant risk of myocarditis in those patients who do not develop severe initial COVID-19 disease.
2019年冠状病毒病（COVID-19）大流行给全球医疗系统造成了巨大损失。在各类患者群体中均出现了重症病例，但心血管疾病患者的病情更为严重，这可能是由于他们存在合并症。在糖尿病、高血压、心力衰竭及其他慢性病患者中，COVID-19表现为凝血功能障碍、心肌炎和心律失常等重症，使这些已有基础疾病的患者病情更加复杂。已有众多研究探讨了COVID-19的心血管并发症。一些更令人担忧的研究结果显示，重症与发生心血管表现的可能性增加之间存在关联。然而，更令人担忧的是，一些研究表明，在先前健康的轻症或无症状COVID-19患者中也存在心肌炎及其他心脏后遗症。本文的目的是回顾文献，汇总关于未发生重症初始COVID-19疾病的患者是否存在心肌炎重大风险的现有信息。
